Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer Novel immunotherapy technology demonstrating ...

A new generation of reversible male contraceptives is advancing through clinical trials to expand family planning options.

CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate ...

Dental Piezoelectric Ultrasonic Unit Market is set to reach USD 265.1 million by 2026-end and grow at a CAGR of 5.0% between 2026-2036 ...

The U.S. Army is evaluating a new manufacturing approach that could speed up missile ...

Tired of the endless political drama and the non-stop doomscrolling? It’s time for a break that actually leaves some positive ...

Hua Medicine ("the Company", stock code: 2552.HK) presented a series of breakthrough research findings on dorzagliatin (Trade name: HuaTangNing, Trade name in ...

This joint-specific response pattern was consistent across all advanced treatment modalities, including abatacept, interleukin-6 receptor inhibitors, Janus kinase inhibitors, rituximab and TNFi.

Objectives Enteral nutrition (EN) constitutes a critical therapeutic intervention in the management of patients with sepsis; however, the optimal timing for its initiation remains uncertain. This ...